ISTH Gene Therapy for Hemophilia
Thank you for taking this survey about gene therapy as a treatment option for hemophilia. The survey is being conducted by the International Society on Thrombosis and Haemostasis. The survey will take approximately 5 minutes to complete. Your participation is voluntary and all responses will be confidential. The results of this survey will help the development of educational programs and content for physicians and other healthcare professionals involved in the care of patients with hemophilia, as well as scientists with an interest in basic, translational, and clinical research in hemophilia and gene therapy.